The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.

Abstract excerpt

Although a successful vaccine against HBV has been implemented in 184 countries, eradication of hepatitis B virus (HBV) is still not on the horizon. There are over 240 million chronic carriers of HBV globally. The risk of developing chronic hepatitis ranges from >90% in newborns of hepatitis Be antigen (HBeAg)-positive mothers, 25%-35% in children under 5 years of age and <5% in adults. HBeAg, a non-particulate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA, Viral
• Share to Genetic Variation
• Share to Genotype